Sort
30,917 grants matching “tumor microenvironment”
Regulation and Function of Mammalian HSF4 in vivo
$257,626Nahid F Mivechi · Augusta University · R01 · FY2011 · CA
Contribution of Epithelial-stromal Interactions to Human Breast Tumor Heterogenei
$257,560Morag Park · Ohio State University · P01 · FY2015 · CA
Contribution of Epithelial-stromal Interactions to Human Breast Tumor Heterogenei
$257,560Morag Park · Ohio State University · P01 · FY2016 · CA
Structural and Drug Screening (SDS)
$257,519Janet L Smith · University Of Michigan At Ann Arbor · P30 · FY2023 · CA
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth
$257,484Constantinos Koumenis · University Of Pennsylvania · R01 · FY2009 · CA
Novel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosis
$257,483Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
A Novel High Throughput Tumor Spheroid Microtechnology
$257,466Hossein Tavana · University Of Akron · R21 · FY2013 · CA
Hypoxia, HIF and Tumorigenesis
$257,446Jaime Caro · Thomas Jefferson University · R01 · FY2006 · CA
T-cell Biofactories for targeting interstitial fluid pressure
$257,409Parijat Bhatnagar · Sri International · R21 · FY2019 · CA
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
$257,378Bumsoo Han · Purdue University · U01 · FY2023 · CA
Project 1-Peruzzi
$257,330Francesca Peruzzi · Lsu Health Sciences Center · P20 · FY2022 · GM
Treating Tumoral Hypoxia via Ultrasound-Guided Oxygen Release for Improving Radiation Therapy
$257,284Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Mechanisms of KSHV-Induced Cellular Transformation
$257,281Ashlee V Moses · Oregon Health & Science University · R01 · FY2013 · CA
Research Pathology Shared Resource
$257,212Amanda L Koehne · Fred Hutchinson Cancer Center · P30 · FY2025 · CA
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth
$257,195Constantinos Koumenis · University Of Pennsylvania · R01 · FY2010 · CA
Polymorphisms in IL-10 Locus Predispose to Preterm Birth
$257,182Women And Infants Hospital-Rhode Island · R01 · FY2003 · HD
Aging and cancer development
$257,125Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Intratumoral Administration of CCL21-gene Modified Dendritic Cell With Intravenous Pembrolizumab for Advanced NSCLC
$257,099Aaron Elliott Lisberg · University Of California Los Angeles · K08 · FY2024 · CA
Intratumoral Administration of CCL21-gene Modified Dendritic Cell With Intravenous Pembrolizumab for Advanced NSCLC
$257,099Aaron Elliott Lisberg · University Of California Los Angeles · K08 · FY2023 · CA
Intratumoral Administration of CCL21-gene Modified Dendritic Cell With Intravenous Pembrolizumab for Advanced NSCLC
$257,099Aaron Elliott Lisberg · University Of California Los Angeles · K08 · FY2020 · CA
Intratumoral Administration of CCL21-gene Modified Dendritic Cell With Intravenous Pembrolizumab for Advanced NSCLC
$257,099Aaron Elliott Lisberg · University Of California Los Angeles · K08 · FY2021 · CA
Intratumoral Administration of CCL21-gene Modified Dendritic Cell With Intravenous Pembrolizumab for Advanced NSCLC
$257,099Aaron Elliott Lisberg · University Of California Los Angeles · K08 · FY2022 · CA
Defining an Integrated Allostatic Load Index with Immune and Tumor Microenvironment Factors
$257,066Richard R Drake · Medical University Of South Carolina · U54 · FY2016 · MD
Core B: Animal Core
$257,035Stefan Niewiesk · Washington University · P01 · FY2025 · CA
Determining Molecular Mechanisms of NSCLC and Response to beta-glucan
$256,974Andrew N Lane · University Of Kentucky · P01 · FY2014 · CA